AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic ... In the study, Nucala was added to inhaled maintenance therapy for COPD. GSK has been studying ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... molecule is as sneaky as its inventors ... COPD and BPD: Inhalation of Live Lactobacilli Lessens Lung Inflammation and Improves ...

Conventionally, inhaled ... COPD and asthma, amounted to $28.1 billion in 2015 and is predicted to expand by a further 50% by 2022. Moreover, there is a worldwide demand for more effective ...

Inhaler colors often are used to identify ... 2016.81 American Lung Association. Asthma and COPD Medicines. National Heart, Lung, and Blood Institute. Asthma treatment and action plan. Asthma and ...

Expert pulmonologists share essential guidelines on distinguishing normal coughs from dangerous ones, plus effective home ...

How many cases of HMPV has India reported? The answer is: more than 15. Meanwhile, China said, “...the increase of reports ...